278 related articles for article (PubMed ID: 27085643)
1. Comparison of two kinds of docetaxel-vitamin E prodrugs: In vitro evaluation and in vivo antitumor activity.
Wang J; Xue P; Zhou J; Li L; Xu L; Wang Y
Int J Pharm; 2016 May; 505(1-2):352-60. PubMed ID: 27085643
[TBL] [Abstract][Full Text] [Related]
2. Docetaxel prodrug liposomes for tumor therapy: characterization, in vitro and in vivo evaluation.
Ren G; Liu D; Guo W; Wang M; Wu C; Guo M; Ai X; Wang Y; He Z
Drug Deliv; 2016 May; 23(4):1272-81. PubMed ID: 26965023
[TBL] [Abstract][Full Text] [Related]
3. Construction and cellular uptake behavior of redox-sensitive docetaxel prodrug-loaded liposomes.
Ren G; Jiang M; Guo W; Sun B; Lian H; Wang Y; He Z
Pharm Dev Technol; 2018 Jan; 23(1):22-32. PubMed ID: 28121230
[TBL] [Abstract][Full Text] [Related]
4. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
Lee E; Kim H; Lee IH; Jon S
J Control Release; 2009 Dec; 140(2):79-85. PubMed ID: 19712714
[TBL] [Abstract][Full Text] [Related]
5. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer.
Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT
Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252
[TBL] [Abstract][Full Text] [Related]
6. Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel.
Raju A; Muthu MS; Feng SS
Expert Opin Drug Deliv; 2013 Jun; 10(6):747-60. PubMed ID: 23458409
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of lipid emulsified docetaxel-loaded nanoparticles.
Zhang F; Chang M; Yu Y; Zhang Y; Liu G; Wei T; Zuo T; Guan Y; Lin G; Zhao Z
J Pharm Pharmacol; 2015 Nov; 67(11):1546-55. PubMed ID: 26256262
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel-loaded RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes: Drug release, cytotoxicity, and antitumor efficacy.
Yoon HY; Kwak SS; Jang MH; Kang MH; Sung SW; Kim CH; Kim SR; Yeom DW; Kang MJ; Choi YW
Int J Pharm; 2017 May; 523(1):229-237. PubMed ID: 28341149
[TBL] [Abstract][Full Text] [Related]
9. Improved anti-tumor efficiency against prostate cancer by docetaxel-loaded PEG-PCL micelles.
Jin MJ; Piao SJ; Jin TX; Jin ZH; Yin XZ; Gao ZG
J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):66-75. PubMed ID: 24496681
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex
Ghassami E; Varshosaz J; Jahanian-Najafabadi A; Minaiyan M; Rajabi P; Hayati E
Int J Nanomedicine; 2018; 13():493-504. PubMed ID: 29416331
[TBL] [Abstract][Full Text] [Related]
11. RGD(Arg-Gly-Asp) internalized docetaxel-loaded pH sensitive liposomes: Preparation, characterization and antitumor efficacy in vivo and in vitro.
Zuo T; Guan Y; Chang M; Zhang F; Lu S; Wei T; Shao W; Lin G
Colloids Surf B Biointerfaces; 2016 Nov; 147():90-99. PubMed ID: 27497073
[TBL] [Abstract][Full Text] [Related]
12. Effective photothermal chemotherapy with docetaxel-loaded gold nanospheres in advanced prostate cancer.
Shen Y; Ma Z; Chen F; Dong Q; Hu Q; Bai L; Chen J
J Drug Target; 2015; 23(6):568-76. PubMed ID: 25738990
[TBL] [Abstract][Full Text] [Related]
13. A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel.
Yang Y; Wang J; Zhang X; Lu W; Zhang Q
J Control Release; 2009 Apr; 135(2):175-82. PubMed ID: 19331864
[TBL] [Abstract][Full Text] [Related]
14. Antitumor Effects of Docetaxel in Truncated Basic Fibroblast Growth Factor- Functionalized Liposomes Delivered by d-α-tocopheryl Polyethylene Glycol 2000 Succinate.
Wen J; Wang Z; Qiu N; Liu H; Shu X; Zhu Z; Bai P; Yang L; Chen L
Curr Pharm Des; 2020; 26(34):4338-4348. PubMed ID: 32324508
[TBL] [Abstract][Full Text] [Related]
15. Tumour microenvironment-responsive lipoic acid nanoparticles for targeted delivery of docetaxel to lung cancer.
Gu F; Hu C; Tai Z; Yao C; Tian J; Zhang L; Xia Q; Gong C; Gao Y; Gao S
Sci Rep; 2016 Nov; 6():36281. PubMed ID: 27805051
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of lipid emulsions of docetaxel-linoleic acid conjugate in breast cancer.
Zhang T; Li M; Yang R; Zhang D; Guan J; Yu J; Yang B; Zhang H; Zhang S; Liu D; Wang Y
Int J Pharm; 2018 Jul; 546(1-2):61-69. PubMed ID: 29763687
[TBL] [Abstract][Full Text] [Related]
17. Formulation optimization of an ephrin A2 targeted immunoliposome encapsulating reversibly modified taxane prodrugs.
Huang ZR; Tipparaju SK; Kirpotin DB; Pien C; Kornaga T; Noble CO; Koshkaryev A; Tran J; Kamoun WS; Drummond DC
J Control Release; 2019 Sep; 310():47-57. PubMed ID: 31400383
[TBL] [Abstract][Full Text] [Related]
18. In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role?
Ostacolo L; Marra M; Ungaro F; Zappavigna S; Maglio G; Quaglia F; Abbruzzese A; Caraglia M
J Control Release; 2010 Dec; 148(2):255-63. PubMed ID: 20816710
[TBL] [Abstract][Full Text] [Related]
19. Improved Bioavailability and Antitumor Effect of Docetaxel by TPGS Modified Proniosomes: In Vitro and In Vivo Evaluations.
Liu H; Tu L; Zhou Y; Dang Z; Wang L; Du J; Feng J; Hu K
Sci Rep; 2017 Mar; 7():43372. PubMed ID: 28266539
[TBL] [Abstract][Full Text] [Related]
20. Eph A10-modified pH-sensitive liposomes loaded with novel triphenylphosphine-docetaxel conjugate possess hierarchical targetability and sufficient antitumor effect both in vitro and in vivo.
Zhang J; Yang C; Pan S; Shi M; Li J; Hu H; Qiao M; Chen D; Zhao X
Drug Deliv; 2018 Nov; 25(1):723-737. PubMed ID: 29513049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]